Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q3 2023 · 10-Q
Revenue$71.44M$71.44M+56.3% vs Q3 2022 Net Income$289.00K$289.00KN/M vs Q3 2022 EPS Diluted$0.00$0.00N/M vs Q3 2022 Gross Profit$15,579,000+68.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,023,000N/M Free Cash Flowderived$1,328,000N/M Margins · derivedGross margin21.8%+1.5 pt vs Q3 2022
Operating margin-10.4%+12.4 pt vs Q3 2022
Net margin0.4%+20.6 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 8, 2023 · 39 d after period end